Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Vizgen webinar: spatial relationships in Developmental Biology
Nov 21, 2023
MERFISH integrates spatial transcriptomics technology with high resolution spatial imaging, In this webinar we will...
Nov 14, 2023
The xCELLigence RTCA eSight enables simultaneous real time biosensor impedance-based and...
NanoCellect webinar: Plant Potential - Gentle Cell Sorting for Enhanced Plant Biology Workflows
Nov 3, 2023
Gentle cell sorting is a useful tool to increase the efficiency of plant biology workflows that include gene...
RareCyte webinar recording: Use of open-source software for quantitative analysis of multiplex image
Nov 1, 2023
In this webinar, Dr. McArdle describes how multiplex immunostaining is a key method for understanding spatial context...
NanoCellect Webinar: Enhancing Genomics Sequencing Data with Gentle Cell Sorting
Oct 6, 2023
With the WOLF Cell Sorter, researchers can easily isolate viable cell samples for genomics workflows before sequencing....
WEBINAR: In Vivo Optical Imaging, unique capabilities and expanding range of applications
Oct 4, 2023
In this educational webinar presented by Andrew D.G. Van Praagh we will discuss the unique strengths of BLI and FLI,...
Cytek webinar recording : introducing the new Autofluorescence (AF) Explorer in Spectroflo 3.2.1
Sep 25, 2023
In this webinar, Cytek will be covering the new features introduced in the newest SpectroFlo 3.2.1 software release and...
Webinar recording: Introducing MARS Platform for gentle cell separation
Sep 6, 2023
Join us for a webinar where we will introduce the new MARS Platform by Applied Cells, a...
Enhancing checkpoint blockade in Lymphoma with in situ vaccination
Apr 6, 2017
During this webinar you will:
- Hear about results of recent clinical trials using novel approaches to enhance checkpoint blockade effectiveness.
- Learn about a unique in situ vaccine design aimed at improving tumor-associated antigen presentation by dendritic cells.
- See how high-resolution profiling with mass cytometry played a key role in defining the effects of these treatments on the intratumoral and systemic immune repertoire in early-phase trials.
Get more info
Brand profile
